Characteristics and Outcomes of US Children and Adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C) Compared with Severe Acute COVID-19

Leora R. Feldstein, Mark W. Tenforde, Kevin G. Friedman, Margaret Newhams, Erica Billig Rose, Heda Dapul, Vijaya L. Soma, Aline B. Maddux, Peter M. Mourani, Cindy Bowens, Mia Maamari, Mark W. Hall, Becky J. Riggs, John S. Giuliano, Aalok R. Singh, Simon Li, Michele Kong, Jennifer E. Schuster, Gwenn E. McLaughlin, Stephanie P. SchwartzTracie C. Walker, Laura L. Loftis, Charlotte V. Hobbs, Natasha B. Halasa, Sule Doymaz, Christopher J. Babbitt, Janet R. Hume, Shira J. Gertz, Katherine Irby, Katharine N. Clouser, Natalie Z. Cvijanovich, Tamara T. Bradford, Lincoln S. Smith, Sabrina M. Heidemann, Sheemon P. Zackai, Kari Wellnitz, Ryan A. Nofziger, Steven M. Horwitz, Ryan W. Carroll, Courtney M. Rowan, Keiko M. Tarquinio, Elizabeth H. Mack, Julie C. Fitzgerald, Bria M. Coates, Ashley M. Jackson, Cameron C. Young, Mary Beth F. Son, Manish M. Patel, Jane W. Newburger, Adrienne G. Randolph

Research output: Contribution to journal › Article › peer-review

551 Scopus citations

Characteristics and Outcomes of US Children and Adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C) Compared with Severe Acute COVID-19

Fingerprint

Medicine & Life Sciences